Literature DB >> 27389078

Complication in diabetic nephropathy.

Sharon John1.   

Abstract

BACKGROUND: Diabetic kidney disease is the most common cause of chronic kidney disease, leading to end-stage renal disease (ESRD) and premature death. In addition, it negatively affects a patient's quality of life and social environment, and poses a burden on national health care budgets. Although various therapeutic approaches, such as hypoglycemic agents, antihypertensive drugs, and renin-angiotensin system inhibitors, have been tried to slow the progression of nephropathy, the number of patients with diabetic kidney disease continues to rise with the prevalence of type 2 diabetes mellitus. Thus, early identification of patients at risk of developing diabetic nephropathy and initiation of appropriate therapy is important to improve patient outcomes. In end stage renal disease (ESRD), diabetic nephropathy is the main cause considered from other diseases.
Copyright © 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27389078     DOI: 10.1016/j.dsx.2016.06.005

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  18 in total

Review 1.  The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease.

Authors:  Hui Bao; Ai Peng
Journal:  J Transl Int Med       Date:  2016-09-23

2.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

3.  Measuring the Awareness of Chronic Kidney Disease (CKD) with Environmental Evaluation among Adult Diabetic Patients in Hail Region, Saudi Arabia.

Authors:  Alreshidi Nahlah Fahad; Abdulrahman Ahmed Alkhateeb; Abdulrahman Rabah Alsharari; Abdulrhman Naif Alharbi; Alazmmy Abdullaziz Hamed
Journal:  J Environ Public Health       Date:  2022-06-29

4.  A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.

Authors:  Md Abdul Hye Khan; Lauren Kolb; Melissa Skibba; Markus Hartmann; René Blöcher; Ewgenij Proschak; John D Imig
Journal:  Diabetologia       Date:  2018-07-21       Impact factor: 10.122

5.  Grem2 mediates podocyte apoptosis in high glucose milieu.

Authors:  Hongxiu Wen; Vinod Kumar; Abheepsa Mishra; Su Song; Rukhsana Aslam; Ali Hussain; Haichao Wang; Xiaogang Zhou; Xiaoming He; Guisheng Wu; Huairong Luo; Xiqian Lan; Ashwani Malhotra; Pravin C Singhal
Journal:  Biochimie       Date:  2019-03-01       Impact factor: 4.079

6.  EDA2R mediates podocyte injury in high glucose milieu.

Authors:  Xiqian Lan; Vinod Kumar; Alok Jha; Rukhsana Aslam; Haichao Wang; Kehong Chen; Yueming Yu; Weimei He; Feilan Chen; Huairong Luo; Ashwani Malhotra; Pravin C Singhal
Journal:  Biochimie       Date:  2020-04-15       Impact factor: 4.079

7.  The ZDSD rat: a novel model of diabetic nephropathy.

Authors:  Richard G Peterson; Charles Van Jackson; Karen M Zimmerman
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

8.  Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate.

Authors:  Lili Qin; Wenjun Qin; Jianfei Wang; Lin Lin
Journal:  Exp Ther Med       Date:  2017-09-12       Impact factor: 2.447

9.  Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.

Authors:  Noel Pabalan; Raphael Enrique Tiongco; Jefferyl Kae Pandac; Noemi Anne Paragas; Shamar Lo Lasta; Nelven Gallego; Hamdi Jarjanazi; Maria Ruth Pineda-Cortel
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

10.  KATP channels in high glucose-induced rat mesangial cell proliferation and release of MMP-2 and fibronectin.

Authors:  Bei Zhang; Yongquan Shi; Junjie Zou; Xiangfang Chen; Wei Tang; Fei Ye; Zhimin Liu
Journal:  Exp Ther Med       Date:  2017-05-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.